Literature DB >> 1446823

Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection.

M Müller1, B Brenig, E L Winnacker, G Brem.   

Abstract

An important aspect of gene transfer into farm animals is the improvement of disease resistance. The mouse Mx1 protein is known to be sufficient to confer resistance to influenza viruses. Gene constructs containing the mouse Mx1 cDNA controlled by the human metallothionein IIA promoter (hMTIIA::Mx), the SV40 early enhancer/promoter region (SV40::Mx) and the mouse Mx1 promoter (mMx::Mx) were transferred into pigs. The results of the gene transfer experiments with the hMTIIA::Mx and the SV40::Mx constructs indicate that the permanent high-level synthesis of Mx1 might be deleterious to the organism: the gene transfer efficiency was surprisingly low, and all transgenic piglets born had rearrangements in their transgene copies that abolished protein synthesis. The use of the interferon (IFN)- and virus-inducible mMx::Mx construct resulted in normal gene transfer efficiency. Two transgenic pig lines could be established which expressed IFN-inducible mouse Mx1 mRNA. Extensive protein analysis did not detect mouse Mx1 in IFN-treated transgenic animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446823     DOI: 10.1016/0378-1119(92)90130-h

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  Biomedical and agricultural applications of animal transgenesis.

Authors:  Alison J Thomson; Jim McWhir
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

2.  The creation of transgenic pigs expressing human proteins using BAC-derived, full-length genes and intracytoplasmic sperm injection-mediated gene transfer.

Authors:  Masahito Watanabe; Mayuko Kurome; Hitomi Matsunari; Kazuaki Nakano; Kazuhiro Umeyema; Akira Shiota; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Transgenic Res       Date:  2011-10-25       Impact factor: 2.788

Review 3.  Animal transgenesis: state of the art and applications.

Authors:  Eduardo O Melo; Aurea M O Canavessi; Mauricio M Franco; Rodolfo Rumpf
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

4.  Production of recombinant human lysozyme in the milk of transgenic pigs.

Authors:  Jia Tong; HengXi Wei; XiaoFang Liu; WenPing Hu; MingJun Bi; YuanYuan Wang; QiuYan Li; Ning Li
Journal:  Transgenic Res       Date:  2010-06-12       Impact factor: 2.788

5.  Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk.

Authors:  Dan Cui; Jia Li; Linlin Zhang; Shen Liu; Xiao Wen; Qiuyan Li; Yaofeng Zhao; Xiaoxiang Hu; Ran Zhang; Ning Li
Journal:  Transgenic Res       Date:  2014-09-19       Impact factor: 2.788

6.  DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish.

Authors:  C H Kim; M C Johnson; J D Drennan; B E Simon; E Thomann; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.

Authors:  Shanora G Brown; Ashley E Knowell; Aisha Hunt; Divya Patel; Sushma Bhosle; Jaideep Chaudhary
Journal:  Prostate       Date:  2014-10-18       Impact factor: 4.104

8.  Modulating mouse innate immunity to RNA viruses by expressing the Bos taurus Mx system.

Authors:  M-M Garigliany; K Cloquette; M Leroy; A Decreux; N Goris; K De Clercq; D Desmecht
Journal:  Transgenic Res       Date:  2009-04-23       Impact factor: 2.788

Review 9.  Precision editing of large animal genomes.

Authors:  Wenfang Spring Tan; Daniel F Carlson; Mark W Walton; Scott C Fahrenkrug; Perry B Hackett
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 10.  Pigs taking wing with transposons and recombinases.

Authors:  Karl J Clark; Daniel F Carlson; Scott C Fahrenkrug
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.